FI128750B - Förfaranden för att fastställa den terapeutiska verkan hos snabbverkande antidepressanter och individualiserad antidepressantterapi i anslutning därtill - Google Patents

Förfaranden för att fastställa den terapeutiska verkan hos snabbverkande antidepressanter och individualiserad antidepressantterapi i anslutning därtill Download PDF

Info

Publication number
FI128750B
FI128750B FI20176142A FI20176142A FI128750B FI 128750 B FI128750 B FI 128750B FI 20176142 A FI20176142 A FI 20176142A FI 20176142 A FI20176142 A FI 20176142A FI 128750 B FI128750 B FI 128750B
Authority
FI
Finland
Prior art keywords
rapid
acting
antidepressant
therapeutic efficacy
determining
Prior art date
Application number
FI20176142A
Other languages
English (en)
Finnish (fi)
Other versions
FI20176142A1 (sv
Inventor
Tomi Rantamäki
Samuel Kohtala
Wiebke Theilmann
Original Assignee
Helsingin Yliopisto
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Helsingin Yliopisto filed Critical Helsingin Yliopisto
Priority to FI20176142A priority Critical patent/FI128750B/sv
Priority to PCT/FI2018/050954 priority patent/WO2019122525A1/en
Publication of FI20176142A1 publication Critical patent/FI20176142A1/sv
Application granted granted Critical
Publication of FI128750B publication Critical patent/FI128750B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4848—Monitoring or testing the effects of treatment, e.g. of medication
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/316—Modalities, i.e. specific diagnostic methods
    • A61B5/369—Electroencephalography [EEG]
    • A61B5/372—Analysis of electroencephalograms
    • A61B5/374—Detecting the frequency distribution of signals, e.g. detecting delta, theta, alpha, beta or gamma waves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/16—Devices for psychotechnics; Testing reaction times ; Devices for evaluating the psychological state
    • A61B5/165—Evaluating the state of mind, e.g. depression, anxiety

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Psychology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
FI20176142A 2017-12-21 2017-12-21 Förfaranden för att fastställa den terapeutiska verkan hos snabbverkande antidepressanter och individualiserad antidepressantterapi i anslutning därtill FI128750B (sv)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FI20176142A FI128750B (sv) 2017-12-21 2017-12-21 Förfaranden för att fastställa den terapeutiska verkan hos snabbverkande antidepressanter och individualiserad antidepressantterapi i anslutning därtill
PCT/FI2018/050954 WO2019122525A1 (en) 2017-12-21 2018-12-20 Methods for determining the effect of rapid-acting antidepressants and personalized antidepressant therapy related thereto

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20176142A FI128750B (sv) 2017-12-21 2017-12-21 Förfaranden för att fastställa den terapeutiska verkan hos snabbverkande antidepressanter och individualiserad antidepressantterapi i anslutning därtill

Publications (2)

Publication Number Publication Date
FI20176142A1 FI20176142A1 (sv) 2019-06-22
FI128750B true FI128750B (sv) 2020-11-30

Family

ID=65228580

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20176142A FI128750B (sv) 2017-12-21 2017-12-21 Förfaranden för att fastställa den terapeutiska verkan hos snabbverkande antidepressanter och individualiserad antidepressantterapi i anslutning därtill

Country Status (2)

Country Link
FI (1) FI128750B (sv)
WO (1) WO2019122525A1 (sv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2571696B (en) 2017-10-09 2020-05-27 Compass Pathways Ltd Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
WO2020212948A1 (en) 2019-04-17 2020-10-22 Compass Pathfinder Limited Methods of treating neurocognitive disorders, chronic pain and reducing inflammation
US20230219889A1 (en) 2020-05-19 2023-07-13 Cybin Irl Limited Deuterated tryptamine derivatives and methods of use
CN112545515B (zh) * 2020-12-04 2022-07-08 清华大学 竞争压力下射击表现检测及评估方法及装置

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007143663A2 (en) * 2006-06-05 2007-12-13 The Regents Of The University Of California Quantitative eeg method to identify individuals at risk for adverse antidepressant effects
US20080159958A1 (en) * 2006-12-27 2008-07-03 Abbott Laboratories Determination of histamine-3 bioactivity
EP2437658B1 (en) 2009-06-03 2019-08-21 MYnd Analytics, Inc. Method for assessing the susceptibility of a human individual suffering from a psychiatric or neurological disorder to neuromodulation treatment
EP3125902B1 (en) * 2014-03-31 2020-09-16 University of Maryland, Baltimore Use of negative modulators of gaba receptors containing alpha5 subunits as fast acting antidepressants
US20170071975A1 (en) 2014-05-12 2017-03-16 Steerwasher, Llc Compositions and methods for treating depressive disorders
WO2016029211A1 (en) 2014-08-22 2016-02-25 The General Hospital Corporation Systems and methods for discovery and characterization of neuroactive drugs

Also Published As

Publication number Publication date
FI20176142A1 (sv) 2019-06-22
WO2019122525A1 (en) 2019-06-27

Similar Documents

Publication Publication Date Title
FI128750B (sv) Förfaranden för att fastställa den terapeutiska verkan hos snabbverkande antidepressanter och individualiserad antidepressantterapi i anslutning därtill
Kohtala Ketamine—50 years in use: from anesthesia to rapid antidepressant effects and neurobiological mechanisms
Naughton et al. A review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action
Pavone et al. Nitrous oxide-induced slow and delta oscillations
Li et al. Antidepressant-like actions of an AMPA receptor potentiator (LY392098)
Yamamoto et al. Psychiatric symptoms of noradrenergic dysfunction: a pathophysiological view
US11964109B2 (en) Systems and methods for driving neural activity to control brain signaling and gene expression
Kohtala et al. Cortical excitability and activation of TrkB signaling during rebound slow oscillations are critical for rapid antidepressant responses
Vonder Haar et al. Frontal traumatic brain injury in rats causes long-lasting impairments in impulse control that are differentially sensitive to pharmacotherapeutics and associated with chronic neuroinflammation
Akeju et al. GABAA circuit mechanisms are associated with ether anesthesia-induced unconsciousness
Kohtala et al. Brief isoflurane anesthesia produces prominent phosphoproteomic changes in the adult mouse hippocampus
Ahnaou et al. Modulation of group II metabotropic glutamate receptor (mGlu2) elicits common changes in rat and mice sleep–wake architecture
Gener et al. Serotonin 5-HT1A, 5-HT2A and dopamine D2 receptors strongly influence prefronto-hippocampal neural networks in alert mice: Contribution to the actions of risperidone
Sood et al. Inhibition of serotonergic medullary raphe obscurus neurons suppresses genioglossus and diaphragm activities in anesthetized but not conscious rats
Ahnaou et al. Negative versus positive allosteric modulation of metabotropic glutamate receptors (mGluR5): indices for potential pro-cognitive drug properties based on EEG network oscillations and sleep-wake organization in rats
Traut et al. Effects of clozapine-N-oxide and compound 21 on sleep in laboratory mice
Siok et al. Comparative analysis of the neurophysiological profile of group II metabotropic glutamate receptor activators and diazepam: effects on hippocampal and cortical EEG patterns in rats
Ahnaou et al. mGlu2 receptor agonism, but not positive allosteric modulation, elicits rapid tolerance towards their primary efficacy on sleep measures in rats
Jonak et al. The PDE10A inhibitor TAK-063 reverses sound-evoked EEG abnormalities in a mouse model of fragile X syndrome
Minelli et al. Effects of intravenous antidepressant drugs on the excitability of human motor cortex: a study with paired magnetic stimulation on depressed patients
Ahnaou et al. Modulation of mGlu2 receptors, but not PDE10A inhibition normalizes pharmacologically-induced deviance in auditory evoked potentials and oscillations in conscious rats
Szabadi Neuronal networks regulating sleep and arousal: effect of drugs
Wang et al. Changes in properties of spinal dorsal horn neurons and their sensitivity to morphine after spinal cord injury in the rat
Carbone et al. Protracted hiccups induced by aripiprazole and regressed after administration of gabapentin
Laitman et al. The α1 adrenoceptor antagonist prazosin enhances sleep continuity in fear-conditioned Wistar–Kyoto rats

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 128750

Country of ref document: FI

Kind code of ref document: B

MM Patent lapsed